oxazolidin-2-one has been researched along with Osteoarthritis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abad, L; Chidiac, C; Diot, A; Ferry, T; Josse, J; Laurent, F; Lustig, S; Tafani, V; Tasse, J; Valour, F | 1 |
| Hu, T; Li, Y; Lin, F; Liu, X; Lu, C; Qiu, Y; Ren, J; Wu, K; Wu, Y; Xiang, L; Xiu, Y; Yang, Y; Zhou, P | 1 |
| García-Ramiro, S; Martínez-Pastor, JC; Mensa, J; Morata, L; Soriano, A; Tornero, E | 1 |
| Beltrand, E; Caillaux, M; Dezeque, H; Dubreuil, L; Legout, L; Lemaire, X; Loïez, C; Migaud, H; Nguyen, S; Senneville, E; Valette, M; Yazdanpanah, Y | 1 |
| Gould, FK | 1 |
2 review(s) available for oxazolidin-2-one and Osteoarthritis
| Article | Year |
|---|---|
Clinical experience with linezolid for the treatment of orthopaedic implant infections.
Topics: Acetamides; Anemia; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gastroenteritis; Gram-Positive Bacterial Infections; Humans; Linezolid; Osteoarthritis; Oxazolidinones; Prosthesis-Related Infections; Treatment Outcome | 2014 |
Linezolid: safety and efficacy in special populations.
Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Osteoarthritis; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; United Kingdom | 2011 |
3 other study(ies) available for oxazolidin-2-one and Osteoarthritis
| Article | Year |
|---|---|
Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
Topics: Anti-Bacterial Agents; Biofilms; Granulocyte Precursor Cells; Humans; Linezolid; Microbial Sensitivity Tests; Models, Theoretical; Osteoarthritis; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tetrazoles | 2019 |
N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Cartilage; Cells, Cultured; Chondrocytes; Ethanolamines; Injections, Intra-Articular; Injections, Intraperitoneal; Interleukin-6; Knee Joint; Male; Matrix Metalloproteinase 13; Osteoarthritis; Oxazolidinones; Pain; Palmitic Acids; PPAR alpha; Pyrrolidines; Rats, Sprague-Dawley; Spinal Cord | 2019 |
Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anemia; Anti-Bacterial Agents; Arthritis, Infectious; Drug Therapy, Combination; Female; Humans; Incidence; Linezolid; Male; Middle Aged; Nervous System Diseases; Osteoarthritis; Oxazolidinones; Rifampin; Thrombocytopenia; Time Factors; Treatment Outcome | 2010 |